Cargando…
A new paradigm shift in antithrombotic therapy
Decades after the introduction of oral anti-coagulants namely the vitamin K antagonist (VKA) Warfarin and antiplatelet agents such as Aspirin and Plavix, new classes of direct, small molecule, novel oral anti-coagulant medications and antiplatelet P2Y12 receptor inhibitors have recently become avail...
Autores principales: | Pudusseri, Anita, Shameem, Raji, Spyropoulos, Alex C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3800773/ https://www.ncbi.nlm.nih.gov/pubmed/24155721 http://dx.doi.org/10.3389/fphar.2013.00133 |
Ejemplares similares
-
The New Oral Anticoagulants for the Treatment of Venous Thromboembolism: A New Paradigm Shift in Antithrombotic Therapy
por: Galanis, Taki, et al.
Publicado: (2014) -
Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development
por: Schenberg, Eduardo Ekman
Publicado: (2018) -
Accelerating Therapeutics for Opportunities in Medicine: A Paradigm Shift in Drug Discovery
por: Hinkson, Izumi V., et al.
Publicado: (2020) -
The “Dynamic” Integrated Database for Pre-Marketing Risk Assessment – A Paradigm Shift
por: Klepper, Michael J.
Publicado: (2012) -
“ISTH guidelines for antithrombotic treatment in COVID‐19”: Reply
por: Schulman, Sam, et al.
Publicado: (2022)